Member Home

Coronavirus (COVID-19)

CDC Situational Update NJDOH nCoV

Trained healthcare professionals are standing by to answer questions about coronavirus. The call is free. NJ residents should call the 24-Hour Public Hotline, called "The NJ Poison Control and Coronavirus Hotline," at 1-800-962-1253.

The NJ Poison Control Center and 211 have partnered with the State to provide information to the public on COVID-19:

Call: 2-1-1 | Text: NJCOVID to 898-211 | Visit: https://covid19.nj.gov/ for additional information

NJHA’s team of Emergency Preparedness and Clinical Affairs professionals are monitoring the 2019 novel Coronavirus (COVID-19), in collaboration with public health agencies. This page compiles key guidance and other resources for the healthcare provider community to support their preparedness and response efforts. NJHA’s Emergency Preparedness office is available 24/7 to healthcare providers at 1-800-457-2262.

Waiver Tracker Hospital Visitation Codes COVID BigShot Site Coronavirus Briefings Key for locked members only page.

Latest Guidance & Resources

CMS Guidance for the Interim Final Rule - Omnibus COVID-19 Health Care Staff — Dec. 29, 2021
Interim Guidance for Managing Healthcare Personnel with SARS-COV-2 Infection or Exposure - Dec. 23, 2021
Strategies to Mitigate Healthcare Personnel Shortage - Dec. 23, 2021
UPDATE: ASPR Pauses Allocation of Certain Monoclonals - Dec. 23, 2021
COVID-19 Recommended Suppliers (Latest update) — March 10,2022
COVID-19 Supplier Considered to Be HIGH RISK — May 11, 2021

Latest Dashboards

Please note dashboards may take a little time to load.

Daily COVID-19 Key for locked members only page.

Key for locked members only page.

Post-Acute COVID-19 Key for locked members only page.

Key for locked members only page.

Guidance

Clinical & Infection Prevention

Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage — July 27, 2021
Investigational COVID-19 Convalescent Plasma — February 2021
Guidance on Integration of COVID-19 in Existing Acute Febrile Illness (AFI) Surveillance Systems | CDC — Updated Jan. 13, 2021
COVID-19 Rapid Response Team Guidance | CDC — Updated Jan. 6, 2021
Interim Guidelines for Clinical Specimens for COVID-19 | CDC — Updated Jan. 6, 2021
Guidance for Cleaning and Disinfecting Public Spaces, Workplaces, Businesses, Schools, and Homes | CDC — Updated Jan. 5, 2021
Information for Pediatric Healthcare Providers | CDC — Updated Dec. 30, 2020
Management of Patients with Confirmed 2019-nCoV | CDC — Updated Dec. 8, 2020
Disposition of Non-Hospitalized Patients with COVID-19 | CDC — Updated Dec. 3, 2020
Preparing for COVID-19: Long-term Care Facilities, Nursing Homes — Updated Nov. 20, 2020
Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic — Updated Nov. 4, 2020
NJDOH Risk Exposure Categories for Asymptomatic Individuals with Possible Exposure to COVID-19 — Updated Oct. 19, 2020
CDC Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (COVID-19) — Updated Oct. 16, 2020
CDC Environmental Cleaning and Disinfection Recommendations — Updated Sept. 10, 2020
Guidance for General Laboratory Safety Practices during the COVID-19 Pandemic — Updated Aug. 24, 2020
COVID-19 Guidance for Shared or Congregate Housing — Updated Aug. 22, 2020
Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in Nursing Homes (REVISED) — Updated Aug. 22, 2020
CDC Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (COVID-19) or Patients Under Investigation for COVID-19 in Healthcare Settings — Updated Jun. 3, 2020
Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings — Updated May. 20, 2020
Information for PACE Organizations Regarding Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) — Mar. 17, 2020
NJDOH Key Messaging to Long-Term Care Facilities — Mar. 4, 2020
Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: Guidance for Industry and Food and Drug Administration Staff — March 2020

Healthcare Personnel

Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2 Infection | CDC — Updated Feb. 14, 2021
COVID-19 Guidance: Businesses and Employers | CDC — Updated Jan. 4, 2021
CDC Interim Guidance for Healthcare Professionals Overview — Updated Oct. 21, 2020
Information for Pediatric Healthcare Providers — Aug. 17, 2020
Families First Coronavirus Response Act: Questions and Answers — Mar. 29, 2020
Guidance for use of Certain Industrial Respirators by Health Care Personnel — Mar. 10, 2020
NJDOH Managing Healthcare Workers (Travelers) Returning from China — Feb. 2, 2020

PPE (Personal Protective Equipment)

Decontamination Systems for Personal Protective Equipment EUAs — Jan. 22, 2021
Summary for Healthcare Facilities: Strategies for Optimizing the Supply of PPE during Shortages | CDC — Updated Dec. 29, 2020
Summary for Healthcare Facilities: Strategies for Optimizing the Supply of N95 Respirators during Shortages | CDC — Updated Dec. 29, 2020
Strategies for Optimizing the Supply of Disposable Medical Gloves | CDC — Updated Dec. 23, 2020
Strategies for Optimizing the Supply of Eye Protection: COVID-19 | CDC — Updated Dec. 22, 2020
CDC Guidance: Strategies for Optimizing the Supply of N95Respirators: Crisis/Alternate Strategies — Updated Nov. 23, 2020
CDC Guidance: Strategies for Optimizing the Supply of Facemasks — Updated Nov. 23, 2020
Strategies for Optimizing the Supply of PPE Based on CDC Guidance v.2 — Oct. 31, 2020
CDC Guidance: Strategies for Optimizing the Supply of Eye Protection — Updated Oct. 27, 2020
CDC Guidance: Strategies for Optimizing the Supply of Isolation Gowns — Updated Oct. 9, 2020
Using Personal Protective Equipment (PPE) — Aug. 19, 2020
Strategies for Optimizing the Supply of PPE Based on CDC Guidance v.1 — Mar. 24, 2020

Testing & Reporting

Overview of Testing for SARS-CoV-2 — Updated Mar. 17, 2020
Interim Guidance on Testing Healthcare Personnel for SARS-CoV-2 | CDC — Updated Feb. 14, 2021
Testing Guidelines for Nursing Homes | CDC — Updated Jan. 7, 2021
Interim Guidance on Developing a COVID-19 Case Investigation & Contact Tracing Plan: Overview | CDC — Updated Jan. 4, 2021
Guidance for SARS-CoV-2 Point-of-Care Testing | CDC — Updated Dec. 30, 2020
Interim SARS-CoV-2 Testing Guidelines for Patients in Outpatient Hemodialysis Facilities | CDC — Updated Dec. 21, 2020
Interim Guidance for Antigen Testing for SARS-CoV-2 | CDC — Updated Dec. 16, 2020
Overview of Testing for SARS-CoV-2 (COVID-19) | CDC — Updated Oct. 21, 2020
Interim Guidelines for COVID-19 Antibody Testing — Aug. 1, 2020
Guidance for Healthcare Workers about COVID-19 (SARS-CoV-2) Testing — July 31, 2020
NJDOH Update and Interim Guidance on New CDC Testing Criteria for 2019 Novel Coronavirus (COVID-19) — Mar. 4, 2020
NJDOH Surveillance Criteria and Testing for Novel Coronavirus 2019 — Jan. 31, 2020

Public Messaging

CDC Interim Guidance: Get Your Mass Gatherings or Large Community Events Ready for Coronavirus Disease 2019 (COVID-19) — Updated Nov. 17, 2020

Regulatory

Executive Directive No. 20-026: Directive for the Resumption of Services in All Long-Term Care Facilities — Jan. 6, 2021
PO 360, General Department — Nov. 16, 2020
Duration of Isolation and Precautions for Adults with COVID-19 — Updated Oct. 19, 2020
OCSME Death Reporting/Certificate Guidance — Mar. 31, 2020

Vaccination

Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage — July 27, 2021
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — July 6, 2021
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — May 14, 2021
Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination — Apr. 27, 2021
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — Apr. 27, 2021
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — Mar. 2, 2021
Johnson & Johnson’s Janssen COVID-19 Vaccine Information | CDC — Mar. 1, 2021
Pfizer-BioNTech COVID-19 Vaccine Information | CDC — Feb. 22, 2021
Moderna COVID-19 Vaccine Information | CDC — Feb. 22, 2021
Vaccinating Homebound Persons With COVID-19 Vaccine — Feb. 11, 2021
COVID-19 Eligible Groups — Jan. 13, 2021
When Vaccine is Limited, Who Should Get Vaccinated First? | CDC — Jan. 8, 2021
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — Jan. 1, 2021
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — Jan. 1, 2021
CDC Interim Guidance on Use of Moderna Vaccine — Dec. 20, 2020
FDA Letter of Emergency Use Authorization – Moderna — Dec. 18, 2020
Equal Employment Opportunity Commission Technical Assistance Questions and Answers — Dec. 16, 2020
CDC Interim Guidance on Use of Pfizer-BioNTech Vaccine — Dec. 13, 2020
FDA Letter of Emergency Use Authorization – Pfizer-BioNTech — Dec. 11, 2020

COVID-19 Testing Reported to NJDOH

Interactive Dashboard by County

Updated: April 15, 2024
Positive*	2,707,984
Deaths	33,740
Total Tests**	n/a
Total Vaccine Doses Administered in NJ***	20,431,483

* Includes deaths and results reported by commercial and medical center laboratories

** The total number of tests that have been reported to the NJDOH using PCR, the most widely used viral testing method. It is not a count of how many people have been tested. Some persons have been tested multiple times, while some tests produce inconclusive results and need to be repeated.

*** Total vaccine doses administered includes dose 1, dose 2 and a small number of doses that do not have a dose number yet indicated at the time of data refresh. Therefore, summing across dose 1 and dose 2 will not exactly match total vaccine administered

Additional Resources

Clinical & Infection Prevention

Interim Guidance on Duration of Isolation and Precautions for Adults with COVID-19 | CDC — Updated Feb. 13, 2021
Clinical Questions about COVID-19: Questions and Answers | CDC — Updated Jan. 25, 2021
COVID-19 Vaccines and Allergic Reactions | CDC — Updated Jan. 22, 2021
How to Make 0.1% Chlorine Solution to Disinfect Surfaces in Healthcare Settings | CDC — Updated Jan. 8, 2021
COVID-19 Toolkit of Resources for Long Term Care Facilities v.3 — November 2020
Key Considerations for Transferring Patients to Relief Healthcare Facilities when Responding to Community Transmission of COVID-19 in the United States — July 30, 2020
COVID-19 Toolkit of Resources for Long Term Care Facilities v.2 — Apr. 10, 2020
COVID-19 Toolkit of Resources for Long Term Care Facilities — Mar. 23, 2020
Ventilator Supply Mitigation Strategies: Letter to Health Care Providers — Mar. 22, 2020
NIOSH-Approved N95 Particulate Filtering Facepiece Respirators — Mar. 12, 2020
CDC Hospital Preparedness Checklist for Suspected or Confirmed COVID-19 Patients — Jan. 25, 2020
Pharmacy-Related COVID-19 Issue Website — New Jersey Pharmacy Association

Healthcare Personnel

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites — May 14, 2020
Strategies to Mitigate Healthcare Personnel Staffing Shortages | CDC — Feb. 14, 2020
Reopen America Staffing Resources | CDC — Jan. 14, 2021
Post Vaccine Considerations for Healthcare Personnel | CDC — Dec. 13, 2020
Healthcare Provider (HCP) COVID-19 Staffing Resource Toolkit v.3 — Oct. 31, 2020
Healthcare Provider (HCP) COVID-19 Staffing Resource Toolkit v.2 — May 16, 2020
Healthcare Provider (HCP) COVID-19 Staffing Resource Toolkit v.1 — Apr. 1, 2020
COVID-19 Scenarios & Benefits Available Infographic — Mar. 16, 2020
What Healthcare Personnel Should Know about Caring for Patients with Confirmed or Possible COVID-19 Infection — Feb. 7, 2020
CDC Healthcare Professional Preparedness Checklist For Transport and Arrival of Patients Potentially Infected with COVID-19 — Jan. 25, 2020
NJDOL Benefits and the Coronavirus (COVID-19): What Employees Should Know
U.S. Department of Labor - COVID-19 and the American Workplace
COVID-19 Patient & Family Communication Resource Guide v.2 — Oct. 31, 2020

PPE (Personal Protective Equipment)

Strategies for Optimizing the Supply of N95 Respirators — Apr. 9, 2021
HBS COVID-19 Solicitor Vetting Process — Updated Mar. 22, 2021
Improve the Fit and Filtration of Your Mask to Reduce the Spread of COVID-19 — Feb. 13, 2021
Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure — Feb. 10, 2021
N95 Respirator Resource Guide v.3 — Oct. 31, 2020
COVID-19 Recommended Suppliers
COVID-19 Supplier Considered to Be HIGH RISK
Implementing Filtering Facepiece Respirator (FFR) Reuse, Including Reuse after Decontamination, When There Are Known Shortages of N95 Respirators — Aug. 4, 2020
Considerations for Release of Stockpiled N95s Beyond the Manufacturer-Designated Shelf Life — July 20, 2020
N95 Respirator Resource Guide v.2 — Apr. 28, 2020
N95 Respirator Resource Guide v.1 — Apr. 9, 2020
Healthcare Supply of Personal Protective Equipment — Feb. 18, 2020

Testing & Reporting

Managing Investigations During an Outbreak — July 31, 2020
CDC Flowchart to Identify and Assess 2019 Novel Coronavirus — Feb. 1, 2020

Public Messaging

NJHA COVID Vaccination Outreach Toolkit (with Resources for Vaccine-Hesitant Groups) — April 2021
Customizable COVID-19 Vaccine Content for Essential Workers | CDC — Updated Feb. 13, 2021
Print Resources | CDC — Updated Feb. 4, 2021
COVID-19 One-Stop Shop Toolkits | CDC — Updated Jan. 28, 2021
Public Service Announcements (PSAs) | CDC — Updated Jan. 14, 2021
Information for Limited-English-Proficient Populations | COVID-19 | CDC — Dec. 22, 2020
Considerations for Wearing Masks: Help Slow the Spread of COVID-19 — Aug. 7, 2020
#StayWellSummer — July 14, 2020
Patient-Family Communication Resource Guide
- COVID-19 Patient & Family Communication Resource Guide v.2 — Oct. 31, 2020
- COVID-19 Patient & Family Communication Resource Guide v.1 — May 15, 2020
- Prevent the Spread of COVID-19 — May 14, 2020
- Prevent the Spread of COVID-19: Spanish — May 14, 2020
- Using Cloth Face Coverings to Help Slow the Spread of COVID-19 — May 14, 2020
- Using Cloth Face Coverings to Help Slow the Spread of COVID-19: Spanish — May 14, 2020
End Virus Bias Tools
- NJHA's End Virus Bias Press Release — Apr. 10, 2020
- CDC Reducing Stigma — Mar. 30, 2020
- UNICEF: Social stigma associated with the coronavirus disease (COVID-19) — Feb. 24, 2020
COVID-19 Communication Card for Deaf/Hard of Hearing — Mar. 19, 2020
Coronavirus: Visitor Restrictions for Hospitals
- Coronavirus Visitor Restrictions — Mar. 11, 2020
- Coronavirus Visitor Restrictions Sign — Mar. 11, 2020
CDC FAQs
- Coronavirus and children — Feb. 22, 2020
- Coronavirus and pregnancy — Feb. 21, 2020
- Stigma related to COVID-19 — Feb. 20, 2020
NJDOH 2019 novel Coronavirus fact sheet (PDF) — January 2020
Symptoms of Coronavirus (COVID-19)

Regulatory

Statement of Cathy Bennett, NJHA President and CEO, on Resumption of Elective Hospital Procedures — May 15, 2020
U.S. Department of Labor Issues Temporary Enforcement Guidance for Respirator Fit-Testing in Healthcare during COVID-19 Outbreak — Mar. 14, 2020
Waiver or Modification of Requirements Under Section 1135 of the Social Security Act — Mar. 13, 2020
COVID-19 Emergency Declaration Health Care Providers Fact Sheet — Mar. 13, 2020
Public Health Emergency Sec. 1135 Waivers — Mar. 13, 2020

Vaccination

New Jersey Vaccine Coordinator Toolkit — May 31, 2021
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites — May 14, 2020
Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination — Apr. 27, 2021
Janssen: EUA Amendment — Apr. 23, 2021
Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers — Apr. 23, 2021
Janssen COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers — Apr. 23, 2021
NJHA COVID Vaccination Outreach Toolkit (with Resources for Vaccine-Hesitant Groups) — April 2021
COVID-19 Vaccine Training Modules — Updated Mar. 6, 2021
Janssen/Johnson & Johnson fact sheets for providers — Updated Feb. 28, 2021
Janssen/Johnson & Johnson vaccine website — Updated Feb. 28, 2021
Janssen/Johnson & Johnson for recipients and caregivers — Feb. 27, 2021
Customizable COVID-19 Vaccine Content for Essential Workers | CDC — Updated Feb. 13, 2021
Importance of COVID-19 Vaccination for Essential Workers | CDC — Updated Jan. 27, 2021
COVID-19 Vaccination Toolkits | CDC — Jan. 16, 2021
Frequently Asked Questions about COVID-19 Vaccination | CDC — Jan. 15, 2021
Department of Health | Communicable Disease Service | COVID-19 Vaccination — Jan. 13, 2021
Vaccination Considerations for People who are Pregnant or Breastfeeding | CDC — Jan. 7, 2021
Information about the Moderna COVID-19 Vaccine | CDC — Updated Jan. 1, 2021
Information about the Pfizer-BioNTech COVID-19 Vaccine | CDC — Jan. 1, 2021
Vaccination Considerations for Persons with Underlying Medical Conditions | CDC — Updated Dec. 29, 2020
Vaccination Considerations for Persons with Underlying Medical Conditions | CDC — Dec. 28, 2020
COVID-19 Vaccination Considerations for Persons with Underlying Medical Conditions | CDC — Dec. 26, 2020
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States — Dec. 20, 2020
FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting — Dec. 17, 2020
FDA EUA for Moderna COVID-19 Vaccine — Dec. 17, 2020
CDC Interim Considerations: Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites — Dec. 16, 2020
Moderna Vaccine Fact Sheet for Recipients and Caregivers — December 2020
Moderna Vaccine Fact Sheet for Healthcare Providers — December 2020
Vaccine Adverse Event Reporting System

Videos

Vaccinatio

Mask Up

Healthcare Heroes

Tools

Resources to download and use

Coronavirus

View Pandemic Planning Tool